bivalirudin
Generic: bivalirudin
Labeler: meitheal pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
bivalirudin
Generic Name
bivalirudin
Labeler
meitheal pharmaceuticals inc.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
bivalirudin 250 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
71288-427
Product ID
71288-427_79d8ee9d-bd04-4fb8-aa3b-61cef7be14f2
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091602
Listing Expiration
2026-12-31
Marketing Start
2018-07-16
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71288427
Hyphenated Format
71288-427
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bivalirudin (source: ndc)
Generic Name
bivalirudin (source: ndc)
Application Number
ANDA091602 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/5mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-427-92) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-427-91)
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "79d8ee9d-bd04-4fb8-aa3b-61cef7be14f2", "openfda": {"nui": ["N0000175980", "N0000175518", "N0000009963"], "unii": ["TN9BEX005G"], "rxcui": ["308769"], "spl_set_id": ["26fb46f6-0088-42b8-b6f2-c67224776803"], "pharm_class_epc": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]"], "pharm_class_moa": ["Thrombin Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (71288-427-92) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-427-91)", "package_ndc": "71288-427-92", "marketing_start_date": "20180716"}], "brand_name": "BIVALIRUDIN", "product_id": "71288-427_79d8ee9d-bd04-4fb8-aa3b-61cef7be14f2", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "71288-427", "generic_name": "BIVALIRUDIN", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BIVALIRUDIN", "active_ingredients": [{"name": "BIVALIRUDIN", "strength": "250 mg/5mL"}], "application_number": "ANDA091602", "marketing_category": "ANDA", "marketing_start_date": "20180716", "listing_expiration_date": "20261231"}